|
AKAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.238400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.871800E-02 |
| Normal-vs-Stage2 |
7.086600E-01 |
| Normal-vs-Stage3 |
3.046000E-01 |
| Normal-vs-Stage4 |
8.777200E-01 |
| Stage1-vs-Stage2 |
6.591200E-01 |
| Stage1-vs-Stage3 |
6.245800E-02 |
| Stage1-vs-Stage4 |
4.542000E-01 |
| Stage2-vs-Stage3 |
3.197400E-01 |
| Stage2-vs-Stage4 |
7.230000E-01 |
| Stage3-vs-Stage4 |
6.280800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.101790E-01 |
| Normal-vs-AfricanAmerican |
7.465600E-01 |
| Normal-vs-Asian |
7.437200E-01 |
| Caucasian-vs-AfricanAmerican |
4.045000E-01 |
| Caucasian-vs-Asian |
5.267400E-01 |
| AfricanAmerican-vs-Asian |
6.896200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.924100E-02 |
| Normal-vs-Female |
5.946800E-01 |
| Male-vs-Female |
4.517200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.960000E-01 |
| Normal-vs-Extreme_Weight |
4.679800E-01 |
| Normal-vs-Obese |
3.680800E-01 |
| Normal-vs-Extreme_Obese |
4.077000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.259200E-01 |
| Normal_Weight-vs-Obese |
2.519800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.662400E-01 |
| Extreme_Weight-vs-Obese |
8.728600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.885200E-01 |
| Obese-vs-Extreme_Obese |
6.181200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.598300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.600000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.209400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.511000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.964000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.941580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.032300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.198980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.103900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.835040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.716780E-03 |
| Normal-VS-Type2 PRCC |
2.558200E-01 |
| Normal-VS-KIRP CIMP |
5.175600E-01 |
| Normal-VS-Unclassified PRCC |
5.642200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.377200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.807900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.190800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.002800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.986180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.988600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.911200E-01 |
| Normal-vs-N1 |
1.669380E-01 |
| Normal-vs-N2 |
6.440000E-01 |
| N0-vs-N1 |
5.158200E-01 |
| N0-vs-N2 |
4.261400E-01 |
| N1-vs-N2 |
2.387400E-01 |
|
|
